Experiment: 8VSW

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
2	2D 1H-13C HSQC	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
14	2D 1H-13C HSQC	0.8 mM [U-10% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
3	3D HNCO	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
5	3D CBCA(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
6	3D HNCACB	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
7	3D H(CCO)NH	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
8	3D C(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
9	3D HCCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
10	2D 1H-1H NOESY	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
11	3D 1H-13C NOESY	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
12	4D 13C,13C NOESY	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	100% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750
13	4D 13C,15N NOESY	0.8 mM [U-100% 13C; U-100% 15N] 4-mercaptophenol-alpha3C, 25 mM [U-100% 2H] sodium acetate, 25 mM sodium chloride, 100 uM DSS	90% H2O/10% D2O	50 mM	5.6	ambient	303	Bruker AVANCE III 750

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	750

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	32
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	Felix		Accelrys Software Inc.
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard
5	data analysis	TALOS+		Cornilescu, Delaglio and Bax
6	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
7	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.